Transfuse Atidars Autotem in Periph Vein, Perc, New Tech 8

This code describes the administration of atidarsagene autotemcel, a gene therapy product, directly into a patient's peripheral vein. This procedure involves the infusion of the patient's own genetically modified hematopoietic stem cells, which have been engineered to express the arylsulfatase A (ARSA) enzyme.

This code is used for patients receiving atidarsagene autotemcel (brand name Lenmeldy) for the treatment of metachromatic leukodystrophy (MLD). The procedure typically follows myeloablative conditioning and involves a single intravenous infusion of the gene therapy product.

• Ensure documentation clearly specifies the administration of atidarsagene autotemcel via a peripheral vein.
• Verify that the procedure is performed as part of a gene therapy treatment for metachromatic leukodystrophy.
• This code is for the infusion itself; separately code any associated conditioning regimens or other supportive care.